Bookmark of this page has been deleted.
Recro Strengthens Leadership Team With Key Executive and Board Appointments
Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial Officer
Recent Appointments, including CEO David Enloe, Provide Experienced Leadership to Drive Growth for Company’s Unique End-to-End CDMO Business in Rapidly Expanding Manufacturing Services Market
MALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) Recro Pharma, Inc. (“Recro”; NASD: REPH), a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the continued strengthening of its leadership through key appointments to its management team and board of directors. Recro named James (“Jim”) Miller, a highly regarded CDMO industry thought leader, to its board of directors. Additionally, the c
Costochondritis Market - Increasing Demand with Industry Professionals by Size, Share and Growth sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Recro Announces Executive Changes David Enloe Named President and Chief Executive Officer
December 16, 2020 07:00 ET | Source: Recro Pharma, Inc. Recro Pharma, Inc. Malvern, Pennsylvania, UNITED STATES
MALVERN, Pa., Dec. 16, 2020 (GLOBE NEWSWIRE) Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products, today announced that David Enloe has been named President, Chief Executive Officer and a member of the Company’s Board of Directors, replacing Gerri Henwood, effective today.
Mr. Enloe brings over two decades of executive leadership experience in biotechnology, clinical drug development and GMP manufacturing to Recro, with a proven track record of building and growing CDMO businesses. Most recentl